Stockreport

21% TLX PLUNGE: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

Telix Pharmaceuticals Limited - American Depositary Shares  (TLX) 
PDF SAN FRANCISCO, Dec. 16, 2025 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Telix Pharmaceuticals Ltd. (N [Read more]